 Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores Panasonic Energy India Company Ltd Q2 FY2026 profit up QoQ at Rs. 1.92 crore
Panasonic Energy India Company Ltd Q2 FY2026 profit up QoQ at Rs. 1.92 crore 
              Mr. Nilesh Ghuge, Institutional Research Analyst, HDFC Securities and Mr. Harshad Katkar, Institutional Research Analyst, HDFC Securities
We maintain SELL on Alkyl Amines with a price target of INR 3,200 (WACC 10%, terminal growth 5%). The stock is currently trading at 55.6x FY23E EPS. We believe that the current valuation already factors in positives from the potential volume growth, post doubling of the acetonitrile plant capacity, and ~40% additional capacities of the aliphatic amines plant. The rising raw material prices are looking as a dampener and can put pressure on the margins in FY22. EBITDA/APAT were 5/1% below our estimates, owing to higher-than-expected raw material costs, offset by lower-than-expected depreciation, higher-than-expected other income, and a lower-than-expected tax outgo.
Financial performance: Sales grew 3/60% QoQ/YoY to INR 3.9bn. Q1 witnessed a volume degrowth of 2-5% sequentially, whereas realisation grew by 5-6%. Gross margin fell significantly to 48.9% (-808/-699bps QoQ/YoY) in Q1 as raw material prices of key inputs such as acetic acid, methanol and ammonia soared in the quarter. EBITDA margin came in at 28.3% (-664/-331bps QoQ/YoY) and witnessed a fall mainly due to the trickle-down effect of a lower gross margin.
Call takeaways: (1) Capex guidance for FY22/23 is INR 2.0/2.5bn. Apart from this, the company is looking for a land parcel of 100-150 acres for its future expansion plans. (2) The acetonitrile expansion project is on track and is expected to finish mechanical completion in Sep-21. The plant will be commissioned in Q3FY22, and will ramp up in Q4FY22. (3) Preliminary work on the aliphatic amines expansion project has been completed. (4) The company is carrying out a brownfield expansion for DMA HCL and is increasing its capacity from 25ktpa to 30ktpa. This capacity should come onstream in Oct'21. (5) There was a planned shutdown of plants in April which also affected sales volumes in Q1FY22.
Change in estimates: We raise our FY22 EPS estimate by 4.9% to INR 65.1 per share to factor in increased realisations across products, offset by higher raw material costs in FY22.
Shares of Alkyl Amines Chemicals Ltd., was last trading in BSE at Rs. 4217.9 as compared to the previous close of Rs. 4206.4. The total number of shares traded during the day was 2900 in over 903 trades.
The stock hit an intraday high of Rs. 4228 and intraday low of 4112.15. The net turnover during the day was Rs. 12100423.